Literature DB >> 28189430

How Reliable are Trial-based Prognostic Models in Real-world Patients with Metastatic Castration-resistant Prostate Cancer?

Fatemeh Seyednasrollah1, Mehrad Mahmoudian2, Liisa Rautakorpi3, Outi Hirvonen4, Tarja Laitinen5, Sirkku Jyrkkiö3, Laura L Elo6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28189430     DOI： 10.1016/j.eururo.2017.01.043

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  1 in total

1.  ePCR: an R-package for survival and time-to-event prediction in advanced prostate cancer, applied to real-world patient cohorts.

Authors:  Teemu D Laajala; Mika Murtojärvi; Arho Virkki; Tero Aittokallio
Journal:  Bioinformatics       Date:  2018-11-15       Impact factor: 6.937
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.